Firm reiterates committment to tackle hypertension, diseases in Africa

A global science-led biopharmaceutical company, AstraZeneca through its innovative programme, Healthy Heart Africa (HHA), has reiterated it commitment in tackling hypertension and the rising burden of cardiovascular diseases (CVDs) and Non-Communicable Diseases (NCDs) in Africa.